ERBB3 and breast cancer: Low total cellular HER3 protein expression was shown to increase the risk of breast cancer recurrence by 2.3-fold relapse risk, positive lymph nodal status 3.5-fold, and tumour size of pT3-pT4 by 4.0-fold (Table 7).